Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Biotech
STAT+
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

What Trump pushback? Bayer takes hefty price hikes on two cancer drugs in just six months

  • Ed Silverman

By Ed Silverman June 7, 2018

Reprints
Markus Schreiber/AP

Even as the Trump administration looks for ways to mollify angry consumers over rising drug prices, some companies continue to push the proverbial envelope.

Take Bayer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed covers the pharmaceutical industry.

Tags

New study sees possible link between aluminum in childhood…
New study sees possible link between aluminum in childhood vaccines and risk of asthma, but caveats…
Surgeons often take a fifth of the lungs to…
Surgeons often take a fifth of the lungs to remove a small tumor. There may be…
Push to double up on Covid booster and flu…
Push to double up on Covid booster and flu shot may have a downside, experts caution
With rivals on its heels, Illumina launches a new…
With rivals on its heels, Illumina launches a new line of high-end DNA sequencers
Pharmalittle: Medicare plans sizable infrastructure for negotiating drug prices;…
Pharmalittle: Medicare plans sizable infrastructure for negotiating drug prices; Alzheimer’s data also boost Roche and Lilly
Medicare lays out the bureaucracy it will need to…
Medicare lays out the bureaucracy it will need to negotiate drug prices

Recommended Stories